Tissue pharmacokinetics of cefazolin in patients with lower limb infections

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 11, 2013, Pages 5679-5683

  Bhalodi, Amira A ^a   Housman, Seth T ^a   Shepard, Ashley ^a   Nugent, James ^a   Nicolau, David P ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; RINGER LACTATE SOLUTION;

ACUTE KIDNEY FAILURE; ADULT; AREA UNDER THE CURVE; ARTICLE; CATHETERIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EXPOSURE; DRUG HALF LIFE; FEMALE; HUMAN; IN VIVO STUDY; LEG DISEASE; MALE; MAXIMUM PLASMA CONCENTRATION; MICRODIALYSIS; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; PROTEIN BINDING; STEADY STATE; WEIGHT; WOUND INFECTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BLOOD PROTEINS; CATHETERS; CEFAZOLIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; LOWER EXTREMITY; MALE; MICROBIAL SENSITIVITY TESTS; MICRODIALYSIS; MIDDLE AGED; PERMEABILITY; PROTEIN BINDING; STAPHYLOCOCCAL INFECTIONS; WOUNDS, PENETRATING;

EID: 84885923868     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01348-13     Document Type: Article

References (19)

1. Hobizal KB, Wukich DK. 2012. Diabetic foot infections: current concept review. Diabet. Foot Ankle 3:18409. doi:10.3402/dfa.v3i0.18409.
2. Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJG, Armstrong DG, Deery HG, Embil JM, Joseph WS, Karchmer AW, Pinzur MS, Senneville E. 2013. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. J. Am. Podiatr. Med. Assoc. 103:2-7.
3. de la Pena A, Liu P, Derendorf H. 2000. Microdialysis in peripheral tissues. Adv. Drug Deliv. Rev. 45:189-216.
4. de Lange EC, de Boer AG, Breimer DD. 2000. Methodological issues in microdialysis sampling for pharmacokinetic studies. Adv. Drug Deliv. Rev. 45:125-148.
5. Kim A, Suecof LA, Sutherland CA, Gao L, Kuti JL, Nicolau DP. 2008. In vivo microdialysis study of the penetration of daptomycin into soft tissues in diabetic versus healthy volunteers. Antimicrob. Agents Chemother. 52:3941-3946.
6. Bulik CC, Wiskirchen DE, Shepard A, Sutherland CA, Kuti JL, Nicolau DP. 2010. Tissue penetration and pharmacokinetics of tigecycline in diabetic patients with chronic wound infections described by using in vivo microdialysis. Antimicrob. Agents Chemother. 54:5209-5213.
7. Dudley MN, Nightingale CH, Drezner AD, Low HB, Quintiliani R. 1984. Comparative penetration of cefonicid and cefazolin into the atrial appendage and pericardial fluid of patients undergoing open-heart surgery. Antimicrob. Agents Chemother. 26:347-350.
8. Bhalodi AA, Crandon JL, Biek D, Nicolau DP. 2012. Efficacy of ceftaroline fosamil in a staphylococcal murine pneumonia model. Antimicrob. Agents Chemother. 56:6160-6165.
9. Craig WA. 1998. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin. Infect. Dis. 26:1-10.
10. Keel RA, Crandon JL, Nicolau DP. 2011. Efficacy of human simulated exposures of ceftaroline administered at 600 milligrams every 12 hours against phenotypically diverse Staphylococcus aureus isolates. Antimicrob. Agents Chemother. 55:4028-4032.
11. Joukhadar C, Muller M. 2005. Microdialysis: current applications in clinical pharmacokinetic studies and its potential role in the future. Clin. Pharmacokinet. 44:895-913.
12. Zhanel GG, Adam HJ, Baxter M, Nichol K, Denisuik A, Lagace-Wiens P, Walkty A, Karlowsky JA, Schweizer F, Hoban DJ. 2012. Antimicrobial susceptibility of 27,123 pathogens isolated from patients in Canadian hospitals: CANWARD study 2007-2011, abstr C2-135. Abstr. 52nd Intersci. Conf. Antimicrob. Agents Chemother.
13. Douglas A, Altukroni M, Udy AA, Roberts MS, Taraporewalla K, Jenkins J, Lipman J, Roberts JA. 2011. The pharmacokinetics of cefazolin in patients undergoing elective & semi-elective abdominal aortic aneurysm open repair surgery. BMC Anesthesiol. 11:5. doi:10.1186/1471-2253 -11-5.
14. Hutschala D, Skhirtladze K, Kinstner C, Mayer-Helm B, Muller M, Wolner E, Tschernko EM. 2007. In vivo microdialysis to measure antibiotic penetration into soft tissue during cardiac surgery. Ann. Thorac. Surg. 84:1605-1610.
15. Douglas A, Udy AA, Wallis SC, Jarrett P, Stuart J, Lassig-Smith M, Deans R, Roberts MS, Taraporewalla K, Jenkins J, Medley G, Lipman J, Roberts JA. 2011. Plasma and tissue pharmacokinetics of cefazolin in patients undergoing elective and semielective abdominal aortic aneurysm open repair surgery. Antimicrob. Agents Chemother. 55:5238-5242.
16. Kirby WM, Regamey C. 1973. Pharmacokinetics of cefazolin compared with four other cephalosporins. J. Infect. Dis. 128(Suppl):S341-S346. doi: 10.1093/infdis/128.Supplement-2.S341.
17. Vella-Brincat JW, Begg EJ, Kirkpatrick CM, Zhang M, Chambers ST, Gallagher K. 2007. Protein binding of cefazolin is saturable in vivo both between and within patients. Br. J. Clin. Pharmacol. 63: 753-757.
18. Keel RA, Crandon JL, Nicolau DP. 2012. Pharmacokinetics and pulmonary disposition of tedizolid and linezolid in a murine pneumonia model under variable conditions. Antimicrob. Agents Chemother. 56:3420-3422.
19. Kuti JL, Nicolau DP. 2012. Levofloxacin penetration into epithelial lining fluid differs between infected and uninfected patients, abstr A-1964. Abstr. 52nd Intersci. Conf. Antimicrob. Agents Chemother.